Rajnish Wellness
RAJNISHWELLNESSLTD NSE
Rajnish Wellness
HealthcareNSE: RAJNISHWELLNESSLTD BSE: 541601 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹40.62 Cr
Volatility
Moderate
P/E Ratio
-7.8
EBITDA
₹-9.22 Cr
Return on Equity
0.21%
Debt to Equity
0
Book Value
₹1.01
EPS
₹0.01
52W High
₹1.03
52W Low
₹0.38
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company is almost debt free.
- Stock is trading at 0.39 times its book value
- Debtor days have improved from 137 to 49.7 days.
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 9.16%
- Company has a low return on equity of -1.95% over last 3 years.
- Promoter holding has decreased over last 3 years: -7.08%
Growth Rate
Revenue Growth
189% higher than
3Y
Net Income Growth
—
Cash Flow Change
-350% lower than
3Y
ROE
-82.93% lower than
3Y
ROCE
-73.39% lower than
3Y
EBITDA Margin (Avg.)
-699% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.51 | 18.51 | 21.62 | 26.98 | 16.3 | 17.42 | 9.06 | 5.77 | 4.56 | 12 | 23.24 | 102 | 31.01 |
| Expenses | 8.48 | 18.47 | 21.33 | 26.44 | 16.29 | 16.94 | 8.92 | 6.38 | 4.39 | 12.22 | 24.61 | 109 | 30.96 |
| Operating Profit | 0.03 | 0.04 | 0.29 | 0.54 | 0.01 | 0.48 | 0.14 | -0.61 | 0.17 | -0.22 | -1.37 | -6.84 | 0.05 |
| OPM % | 0.35% | 0.22% | 1.34% | 2% | 0.06% | 2.76% | 1.55% | -10.57% | 3.73% | -1.83% | -5.9% | -6.71% | 0.16% |
| Other Income | 0.83 | 0.23 | 0 | 0 | 0.35 | 0 | 0.01 | 0.16 | 0.12 | 0.31 | 0.37 | 0.02 | 0.08 |
| Interest | 0.13 | 0.14 | 0.12 | 0.11 | 0.13 | 0.1 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.01 | 0.01 | 0.01 |
| PBT | 0.73 | 0.13 | 0.17 | 0.42 | 0.23 | 0.37 | 0.1 | -0.46 | 0.29 | 0.09 | -1.01 | -6.83 | 0.12 |
| Tax % | 24.66% | 23.08% | 35.29% | 30.95% | 26.09% | 24.32% | 20% | 0% | 27.59% | 22.22% | -9.9% | -31.19% | 0% |
| Net Profit | 0.55 | 0.1 | 0.1 | 0.28 | 0.17 | 0.28 | 0.07 | -0.46 | 0.22 | 0.06 | -0.91 | -4.7 | 0.12 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.05 | 0 |
Profit & Loss
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25 | 28 | 42 | 14 | 13 | 26 | 26 | 77 | 49 | 142 | 168 |
| Expenses | 24 | 24 | 35 | 14 | 17 | 27 | 27 | 75 | 49 | 151 | 177 |
| Operating Profit | 1 | 3 | 7 | 0 | -3 | 0 | -1 | 2 | 0 | -9 | -8 |
| OPM % | 4.7% | 12% | 16% | 1% | -24% | -0.7% | -4.3% | 2.6% | 0% | -6% | -5% |
| Other Income | 0 | 1 | 0 | 0 | 4 | 1 | 2 | 0 | 1 | 1 | 1 |
| Interest | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 1 | 4 | 6 | -1 | 0 | 0 | 1 | 1 | 0 | -8 | -8 |
| Tax % | 33% | 33% | 28% | -2% | 18% | 15% | 27% | 29% | 25% | -25% | — |
| Net Profit | 1 | 2 | 4 | -1 | 0 | 0 | 0 | 1 | 0 | -6 | -5 |
| EPS in Rs | 0.94 | 0.06 | 0.08 | -0.01 | 0 | 0.01 | 0 | 0.01 | 0 | -0.06 | -0.06 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 3 | 5 | 5 | 5 | 11 | 77 | 77 | 77 | 102 |
| Reserves | 1 | 3 | 18 | 17 | 17 | 12 | 6 | 7 | 7 | 1 |
| Borrowings | 3 | 4 | 5 | 8 | 0 | 0 | 10 | 5 | 0 | 0 |
| Other Liabilities | 5 | 8 | 5 | 4 | 13 | 13 | 6 | 17 | 7 | 6 |
| Total Liabilities | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 91 | 109 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 8 |
| Other Assets | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 88 | 101 |
| Total Assets | 8 | 18 | 32 | 33 | 35 | 35 | 99 | 106 | 91 | 109 |
Cash Flow
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -2 | -3 | -9 | -7 | 0 | 0 | -62 | 2 | -4 | -9 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | -7 |
| Financing | 1 | 3 | 10 | 5 | 0 | 1 | 62 | -2 | -5 | 25 |
| Net Cash Flow | 0 | 0 | 1 | -1 | 0 | 1 | -1 | 0 | 0 | 9 |
| Free Cash Flow | -2 | -3 | -9 | -7 | 0 | 0 | -62 | 2 | -4 | -9 |
| CFO/OP | -136 | -90 | -118 | -4,650 | -4 | -32 | 5,577 | 105 | -41,900 | 94 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59 | 182 | 164 | 318 | 460 | 224 | 287 | 160 | 201 | 50 |
| Inventory Days | 152 | 75 | 77 | 48 | 27 | 32 | 59 | 48 | 79 | 35 |
| Days Payable | 121 | 145 | 27 | 56 | 50 | 17 | 55 | 78 | 31 | 7 |
| Cash Conversion Cycle | 90 | 111 | 214 | 310 | 436 | 238 | 290 | 130 | 249 | 77 |
| Working Capital Days | 30 | 102 | 183 | 702 | 791 | 407 | 449 | 305 | 530 | 182 |
| ROCE % | — | 65% | 37% | 1% | 2% | 3% | 1% | 2% | 1% | -9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Rajnish Wellness insights
58 extracted metrics + investor summaries across FY16–FY26.
Documents
1
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
21 Apr - Rajnish Wellness confirms it is not a Large Corporate as of 31 March 2026. 21 Apr - Rajnish Wellness confirms it is not a Large Corporate as of 31 March 2026.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
10h - Rajnish Wellness confirms it is not a Large Corporate as of 31 March 2026. 10h - Rajnish Wellness confirms it is not a Large Corporate as of 31 March 2026.
4
Closure of Trading Window
25 Mar - Trading window closed from April 1, 2026 until 48 hours after audited financial results for FY ended March 31, 2026. 25 Mar - Trading window closed from April 1, 2026 until 48 hours after audited financial results for FY ended March 31, 2026.
5
Announcement under Regulation 30 (LODR)-Credit Rating
8h - India Ratings upgraded/assigned IND A+/Stable/IND A1 for two INR1,000 million bank facilities on Mar 6, 2026. 8h - India Ratings upgraded/assigned IND A+/Stable/IND A1 for two INR1,000 million bank facilities on Mar 6, 2026.
Frequently Asked Questions about Rajnish Wellness
What does Rajnish Wellness Ltd do?
Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.[1]
Where is Rajnish Wellness Ltd (541601) listed?
Rajnish Wellness Ltd trades as RAJNISHWELLNESSLTD on the NSE and under code 541601 on the BSE.
Which sector does Rajnish Wellness Ltd belong to?
Rajnish Wellness Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Rajnish Wellness Ltd?
Rajnish Wellness Ltd has a market capitalisation of ₹40.62 Cr, which places it in the Small Cap band.
What is the PE ratio of Rajnish Wellness Ltd?
Rajnish Wellness Ltd trades at a PE ratio of -7.80, on earnings per share of ₹0.01, against a book value of ₹1.01 per share.
What is the 52-week high and low of Rajnish Wellness Ltd?
Over the last 52 weeks Rajnish Wellness Ltd has traded between ₹0.38 and ₹1.03.
What is the Return on Equity (ROE) of Rajnish Wellness Ltd?
Rajnish Wellness Ltd reported a return on equity of 0.21%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.[1]
Website rajnishwellness.com
CEO Mr. Rajnishkumar Surendra Prasad Singh
Employees 17
Listed 2018-07-09
Face Value ₹ 1
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/541601.md for Rajnish Wellness Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.